Search research articles
Contact Us
Filters
Showing results (31-40 of 81) with videos related to
Page
of 9
Sort By:
Molecular Pharmaceutics
|
June 29, 2026
The Impact of Plasticizer Polarity on the Permeability of Hydroxypropyl Methylcellulose Phthalate Films
Naitik Jariwala, Samuel De Kerpel, Becky Provinciael, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
September 24, 2004
Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies
Sigrid Hatse, Katrien Princen, Sandra Liekens, et al.
Antiviral Research
|
May 20, 2022
SARS-CoV-2 Permissive glioblastoma cell line for high throughput antiviral screening
Emiel Vanhulle, Joren Stroobants, Becky Provinciael, et al.
Antiviral Research
|
October 2, 2022
Development and optimization of biologically contained Marburg virus for high-throughput antiviral screening
Bert Vanmechelen, Joren Stroobants, Winston Chiu, et al.
International Journal of Molecular Sciences
|
December 11, 2025
Effect of the Bacterial Chaperones SecB and Trigger Factor (TF) on the Folding Dynamics and In Vitro Translocation of Cytoplasmic and Secretory Model Proteins
Ying Xu, Haitham Sedky, Dries Smets, et al.
Virus Research
|
October 17, 2019
A unique class of lignin derivatives displays broad anti-HIV activity by interacting with the viral envelope
Merel Oeyen, Sam Noppen, Emiel Vanhulle, et al.
The Journal of Biological Chemistry
|
May 29, 2010
Microvirin, a novel alpha(1,2)-mannose-specific lectin isolated from Microcystis aeruginosa, has anti-HIV-1 activity comparable with that of cyanovirin-N but a much higher safety profile
Dana Huskens, Geoffrey Férir, Kurt Vermeire, et al.
Journal of Medicinal Chemistry
|
August 2, 2011
Unsymmetrical cyclotriazadisulfonamide (CADA) compounds as human CD4 receptor down-modulating agents
Violeta G Demillo, Florian Goulinet-Mateo, Jessica Kim, et al.
Antiviral Research
|
March 26, 2022
Identification of novel Ebola virus inhibitors using biologically contained virus
Bert Vanmechelen, Joren Stroobants, Winston Chiu, et al.
AIDS (London, England)
|
December 4, 2004
CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro
Kurt Vermeire, Katrien Princen, Sigrid Hatse, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 81) with videos related to
Sort By:
Page
of 9
Molecular Pharmaceutics
|
June 29, 2026
The Impact of Plasticizer Polarity on the Permeability of Hydroxypropyl Methylcellulose Phthalate Films
Naitik Jariwala, Samuel De Kerpel, Becky Provinciael, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
September 24, 2004
Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies
Sigrid Hatse, Katrien Princen, Sandra Liekens, et al.
Antiviral Research
|
May 20, 2022
SARS-CoV-2 Permissive glioblastoma cell line for high throughput antiviral screening
Emiel Vanhulle, Joren Stroobants, Becky Provinciael, et al.
Antiviral Research
|
October 2, 2022
Development and optimization of biologically contained Marburg virus for high-throughput antiviral screening
Bert Vanmechelen, Joren Stroobants, Winston Chiu, et al.
International Journal of Molecular Sciences
|
December 11, 2025
Effect of the Bacterial Chaperones SecB and Trigger Factor (TF) on the Folding Dynamics and In Vitro Translocation of Cytoplasmic and Secretory Model Proteins
Ying Xu, Haitham Sedky, Dries Smets, et al.
Virus Research
|
October 17, 2019
A unique class of lignin derivatives displays broad anti-HIV activity by interacting with the viral envelope
Merel Oeyen, Sam Noppen, Emiel Vanhulle, et al.
The Journal of Biological Chemistry
|
May 29, 2010
Microvirin, a novel alpha(1,2)-mannose-specific lectin isolated from Microcystis aeruginosa, has anti-HIV-1 activity comparable with that of cyanovirin-N but a much higher safety profile
Dana Huskens, Geoffrey Férir, Kurt Vermeire, et al.
Journal of Medicinal Chemistry
|
August 2, 2011
Unsymmetrical cyclotriazadisulfonamide (CADA) compounds as human CD4 receptor down-modulating agents
Violeta G Demillo, Florian Goulinet-Mateo, Jessica Kim, et al.
Antiviral Research
|
March 26, 2022
Identification of novel Ebola virus inhibitors using biologically contained virus
Bert Vanmechelen, Joren Stroobants, Winston Chiu, et al.
AIDS (London, England)
|
December 4, 2004
CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro
Kurt Vermeire, Katrien Princen, Sigrid Hatse, et al.
Page
of 9